Final report of University Hospital Hradec Kralove to the clinical trial protocol no. B3271004

Abstract

A Randomized, Double-blind Pharmacokinetic Study of PF-05280014 Plus Taxotere and Carboplatin Versus Herceptin Plus Taxotere And Carboplatin For The Neoadjuvant Treatment Of Patients With Operable HER2-Positive Breast Cancer

Keywords

• PF-05280014
• Taxotere
• Carboplatin
• Herceptin
• Breast Cancer